Edaravone alleviates cell apoptosis and mitochondrial injury in ischemia-reperfusion-induced kidney injury via the JAK/STAT pathway

Abstract Background: Kidney ischemia-reperfusion injury is a common pathophysiological phenomenon in the clinic. A large number of studies have found that the tyrosine protein kinase/signal transducer and activator of transcription (JAK/STAT) pathway is involved in the development of a variety of k...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhao,Xiaoying, Zhang,Erfei, Ren,Xiaofen, Bai,Xiaoli, Wang,Dongming, Bai,Ling, Luo,Danlei, Guo,Zheng, Wang,Qiang, Yang,Jianxin
Lenguaje:English
Publicado: Sociedad de Biología de Chile 2020
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602020000100224
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0716-97602020000100224
record_format dspace
spelling oai:scielo:S0716-976020200001002242020-07-27Edaravone alleviates cell apoptosis and mitochondrial injury in ischemia-reperfusion-induced kidney injury via the JAK/STAT pathwayZhao,XiaoyingZhang,ErfeiRen,XiaofenBai,XiaoliWang,DongmingBai,LingLuo,DanleiGuo,ZhengWang,QiangYang,Jianxin Ischemia-reperfusion injury Edaravone JAK/STAT Mitochondria Abstract Background: Kidney ischemia-reperfusion injury is a common pathophysiological phenomenon in the clinic. A large number of studies have found that the tyrosine protein kinase/signal transducer and activator of transcription (JAK/STAT) pathway is involved in the development of a variety of kidney diseases and renal protection associated with multiple drugs. Edaravone (EDA) is an effective free radical scavenger that has been used clinically for the treatment of postischemic neuronal injury. This study aimed to identify whether EDA improved kidney function in rats with ischemia-reperfusion injury by regulating the JAK/STAT pathway and clarify the underlying mechanism. Methods: Histomorphological analysis was used to assess pathological kidney injury, and mitochondrial damage was observed by transmission electron microscopy. Terminal deoxynucleotidyl transferase-mediated dUTP nick endlabeling (TUNEL) staining was performed to detect tubular epithelial cell apoptosis. The expression of JAK2, P-JAK2, STAT3, P-STAT3, STAT1, P-STAT1, BAX and Bcl-2 was assessed by western blotting. Mitochondrial function in the kidney was assessed by mitochondrial membrane potential (ΔΨm) measurement. Results: The results showed that EDA inhibited the expression of p-JAK2, p-STAT3 and p-STAT1, accompanied by downregulation of the expression of Bax and caspase-3, and significantly ameliorated kidney damage caused by ischemia-reperfusion injury (IRI). Furthermore, the JC-1 dye assay showed that edaravone attenuated ischemia-reperfusion-induced loss of kidney ΔΨm. Conclusion: Our findings indicate that EDA protects against kidney damage caused by ischemia-reperfusion through JAK/STAT signaling, inhibiting apoptosis and improving mitochondrial injury.info:eu-repo/semantics/openAccessSociedad de Biología de ChileBiological Research v.53 20202020-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602020000100224en10.1186/s40659-020-00297-0
institution Scielo Chile
collection Scielo Chile
language English
topic Ischemia-reperfusion injury
Edaravone
JAK/STAT
Mitochondria
spellingShingle Ischemia-reperfusion injury
Edaravone
JAK/STAT
Mitochondria
Zhao,Xiaoying
Zhang,Erfei
Ren,Xiaofen
Bai,Xiaoli
Wang,Dongming
Bai,Ling
Luo,Danlei
Guo,Zheng
Wang,Qiang
Yang,Jianxin
Edaravone alleviates cell apoptosis and mitochondrial injury in ischemia-reperfusion-induced kidney injury via the JAK/STAT pathway
description Abstract Background: Kidney ischemia-reperfusion injury is a common pathophysiological phenomenon in the clinic. A large number of studies have found that the tyrosine protein kinase/signal transducer and activator of transcription (JAK/STAT) pathway is involved in the development of a variety of kidney diseases and renal protection associated with multiple drugs. Edaravone (EDA) is an effective free radical scavenger that has been used clinically for the treatment of postischemic neuronal injury. This study aimed to identify whether EDA improved kidney function in rats with ischemia-reperfusion injury by regulating the JAK/STAT pathway and clarify the underlying mechanism. Methods: Histomorphological analysis was used to assess pathological kidney injury, and mitochondrial damage was observed by transmission electron microscopy. Terminal deoxynucleotidyl transferase-mediated dUTP nick endlabeling (TUNEL) staining was performed to detect tubular epithelial cell apoptosis. The expression of JAK2, P-JAK2, STAT3, P-STAT3, STAT1, P-STAT1, BAX and Bcl-2 was assessed by western blotting. Mitochondrial function in the kidney was assessed by mitochondrial membrane potential (ΔΨm) measurement. Results: The results showed that EDA inhibited the expression of p-JAK2, p-STAT3 and p-STAT1, accompanied by downregulation of the expression of Bax and caspase-3, and significantly ameliorated kidney damage caused by ischemia-reperfusion injury (IRI). Furthermore, the JC-1 dye assay showed that edaravone attenuated ischemia-reperfusion-induced loss of kidney ΔΨm. Conclusion: Our findings indicate that EDA protects against kidney damage caused by ischemia-reperfusion through JAK/STAT signaling, inhibiting apoptosis and improving mitochondrial injury.
author Zhao,Xiaoying
Zhang,Erfei
Ren,Xiaofen
Bai,Xiaoli
Wang,Dongming
Bai,Ling
Luo,Danlei
Guo,Zheng
Wang,Qiang
Yang,Jianxin
author_facet Zhao,Xiaoying
Zhang,Erfei
Ren,Xiaofen
Bai,Xiaoli
Wang,Dongming
Bai,Ling
Luo,Danlei
Guo,Zheng
Wang,Qiang
Yang,Jianxin
author_sort Zhao,Xiaoying
title Edaravone alleviates cell apoptosis and mitochondrial injury in ischemia-reperfusion-induced kidney injury via the JAK/STAT pathway
title_short Edaravone alleviates cell apoptosis and mitochondrial injury in ischemia-reperfusion-induced kidney injury via the JAK/STAT pathway
title_full Edaravone alleviates cell apoptosis and mitochondrial injury in ischemia-reperfusion-induced kidney injury via the JAK/STAT pathway
title_fullStr Edaravone alleviates cell apoptosis and mitochondrial injury in ischemia-reperfusion-induced kidney injury via the JAK/STAT pathway
title_full_unstemmed Edaravone alleviates cell apoptosis and mitochondrial injury in ischemia-reperfusion-induced kidney injury via the JAK/STAT pathway
title_sort edaravone alleviates cell apoptosis and mitochondrial injury in ischemia-reperfusion-induced kidney injury via the jak/stat pathway
publisher Sociedad de Biología de Chile
publishDate 2020
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602020000100224
work_keys_str_mv AT zhaoxiaoying edaravonealleviatescellapoptosisandmitochondrialinjuryinischemiareperfusioninducedkidneyinjuryviathejakstatpathway
AT zhangerfei edaravonealleviatescellapoptosisandmitochondrialinjuryinischemiareperfusioninducedkidneyinjuryviathejakstatpathway
AT renxiaofen edaravonealleviatescellapoptosisandmitochondrialinjuryinischemiareperfusioninducedkidneyinjuryviathejakstatpathway
AT baixiaoli edaravonealleviatescellapoptosisandmitochondrialinjuryinischemiareperfusioninducedkidneyinjuryviathejakstatpathway
AT wangdongming edaravonealleviatescellapoptosisandmitochondrialinjuryinischemiareperfusioninducedkidneyinjuryviathejakstatpathway
AT bailing edaravonealleviatescellapoptosisandmitochondrialinjuryinischemiareperfusioninducedkidneyinjuryviathejakstatpathway
AT luodanlei edaravonealleviatescellapoptosisandmitochondrialinjuryinischemiareperfusioninducedkidneyinjuryviathejakstatpathway
AT guozheng edaravonealleviatescellapoptosisandmitochondrialinjuryinischemiareperfusioninducedkidneyinjuryviathejakstatpathway
AT wangqiang edaravonealleviatescellapoptosisandmitochondrialinjuryinischemiareperfusioninducedkidneyinjuryviathejakstatpathway
AT yangjianxin edaravonealleviatescellapoptosisandmitochondrialinjuryinischemiareperfusioninducedkidneyinjuryviathejakstatpathway
_version_ 1718441605996740608